The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.
The results, published in Science Immunology, are promising enough for AstraZeneca to launch the second phase of the trial, which will involve 200 patients.
AstraZeneca is indicating it can meet orders for its Covid vaccine from various countries simultaneously. It’s a laudable aspiration that needs to be achieved.
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
COMMENTS